Sara Bonstein - May 13, 2024 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chief Financial Officer
Signature
/s/ Sara Bonstein, by Michael A. Smith as Attorney-in-fact
Stock symbol
INSM
Transactions as of
May 13, 2024
Transactions value $
-$280,748
Form type
4
Date filed
5/15/2024, 04:32 PM
Previous filing
Jan 11, 2024
Next filing
May 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Award +14.5K +12.73% 129K May 13, 2024 Direct F1, F2
transaction INSM Common Stock Sale -$281K -11.1K -8.62% $25.32 117K May 14, 2024 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Award $0 +71.2K $0.00 71.2K May 13, 2024 Common Stock 71.2K $25.83 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F2 Each RSU was granted on May 13, 2024 for no consideration.
F3 Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.
F4 This is the weighted average sales price representing 11,088 shares sold at prices ranging from $25.28 to $25.36 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5 These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date.